Skip to main content
CGC logo

CGC · Canopy Growth Corp · Financials

Track CGC — free
$0.72 +0.00 (+0.60%) At close · Oct 20
Market Cap
$304.59M
Shares
423.04M
Volume · Oct 20 1.56M Avg daily vol (3M) 2.92M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
284.6M +5.8%
FY2026 Revenue FY2017–FY2026
Net Income
-262.91M +48.3%
FY2026 Net Income FY2017–FY2026
Gross Margin
24.48% -5.1pp
FY2026 Gross Margin FY2017–FY2026
Operating Margin
-56.8% -13.2pp
FY2026 Operating Margin FY2017–FY2026
Diluted EPS
-0.88 +81.4%
FY2026 Diluted EPS FY2019–FY2026
Operating Cash Flow
-63.81M +61.5%
FY2026 Operating Cash Flow FY2017–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
CAD 284.6M 269M 297.15M 333.25M 475.7M 546.65M 398.77M 226.34M 77.95M 39.9M
CAD — — — — -9.57M — — — — —
CAD 214.93M 189.48M 216.26M 396.78M 663.11M 479.69M 430.46M 198.1M 44.96M —
CAD 69.67M 79.51M 80.88M -63.53M -187.41M 66.96M -31.68M 28.25M 32.99M 38.71M
CAD 2.61M 2.74M 4.61M 21.72M 32.26M 57.58M 61.81M 15.24M 2.05M 810K
CAD — — — — — — — 154.39M 38.2M 12.96M
CAD — — — — — — — 168.43M 6.45M 1.99M
CAD 159.98M 169.63M 229.43M 342.52M 415.45M 575.39M 693.74M 392.25M 103.48M —
CAD 17.45M 21.6M 24.8M 24.46M 34.81M 56.2M 51.3M 16.86M 11.76M —
CAD — — — — — — — 21.51M 12.89M 6.06M
CAD 231.33M 196.65M 309.6M 2.57B 831.39M 1.31B 1.64B 665.7M 152.59M —
CAD -161.66M -117.14M -228.71M -2.63B -1.02B -1.24B -1.67B -637.45M -119.6M -14.08M
CAD 38.19M 74.57M 105.35M 126.16M 103.94M 8.46M 6.72M 2.04M 784K —
CAD -101.23M -390.62M -279.05M -455.64M 751.04M -387.88M 224.33M -59.71M 69.61M —
CAD — — — — -100K -52.63M -64.42M -10.75M -1.47M —
CAD -262.89M -507.76M -507.77M -3.09B -267.86M -1.68B -1.51B -707.91M -51.46M -10.28M
CAD 23K 7.14M 12.33M -5.73M -8.95M -13.14M -121.61M 4.11M -392K -2.7M
CAD — — — -1.9M -4.37M 74.1M -66.11M 24.26M 16.22M —
CAD -252.91M -495.76M -706.93M -3.22B -334.22M -2B -1.09B -742.76M -47.97M —
shares 298.04M 107.55M 74.79M 46.37M 39.13M 37.17M 34.8M 26.7M 17.73M —
shares 298.04M 107.55M 74.79M 46.37M 39.13M 37.17M 34.8M 26.7M 17.73M —
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Long-term debt, including current maturities 2026-06-30 CAD 240,203,000 10-Q filed 2026-08-07
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of long-term debt
CAD 28,824,000
Noncurrent debt carrying amount
CAD 211,379,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 1.79×
EV/EBIT
—
Peer median 13.62×
P/E (TTM)
—
Peer median 15.35×

Peer medians compare against the 52 similar-size Drug Manufacturers - Specialty & Generic companies (of 101 listed).

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (CAD)

Component FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Cannabis 213,944,000 186,726,000 191,683,000 — — — — —
Cannabis Net Revenue 213,944,000 186,726,000 191,683,000 — — — — —
Storz and Bickel 70,659,000 82,269,000 79,464,000 64,845,000 85,410,000 80,998,000 — —
This Works 0 0 21,256,000 26,029,000 32,296,000 33,314,000 — —
All Other Segments 0 0 4,743,000 7,985,000 20,777,000 — — —
BioSteel — — — 69,649,000 34,622,000 28,530,000 — —
Canada Cannabis — 155,860,000 159,165,000 195,445,000 257,910,000 285,049,000 — —
Canadian Cannabis Net Revenue — 155,860,000 159,165,000 195,445,000 257,910,000 285,049,000 225,296,000 182,201,000
Canadian Medical Cannabis Net Revenue — — 61,346,000 55,798,000 52,608,000 55,448,000 51,647,000 65,221,000
Canadian Recreational Cannabis Net Revenue — — 92,370,000 131,269,000 205,302,000 229,601,000 173,649,000 116,980,000
Consumer Products and Other — — — — 183,109,000 167,969,000 103,837,000 33,897,000
Global Cannabis — — — — 337,216,000 378,680,000 294,935,000 192,444,000
Global Cannabis Net Revenue — — — — 337,216,000 378,680,000 294,935,000 192,444,000
International Markets Cannabis — 39,734,000 41,312,000 38,949,000 79,306,000 93,631,000 69,639,000 10,243,000
Other Consumer Products — — — 16,365,000 20,777,000 25,127,000 103,837,000 33,897,000
Other Revenue — — — — — — 105,501,000 34,049,000

By Geography (CAD)

Component FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Canada 186,092,000 155,912,000 162,712,000 201,417,000 268,348,000 329,172,000 256,166,000 198,476,000
Germany 62,072,000 59,904,000 52,194,000 48,701,000 90,874,000 116,379,000 93,945,000 17,894,000
United States 28,270,000 35,990,000 40,988,000 36,431,000 65,475,000 64,926,000 24,568,000 9,965,000
Other Geographical Area 8,169,000 17,189,000 41,252,000 46,704,000 51,002,000 36,172,000 24,093,000 6,000

By Product & Service (CAD)

Component FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Storz Bickel 70,659,000 82,269,000 79,464,000 64,845,000 85,410,000 80,998,000 48,329,000 17,768,000
International Markets Cannabis 28,654,000 30,866,000 32,518,000 38,949,000 79,306,000 — — —
Other Revenue 0 0 4,743,000 7,985,000 20,777,000 25,127,000 42,063,000 26,372,000
This Work 0 0 21,256,000 26,029,000 32,296,000 33,314,000 24,725,000 —
BioSteel — — — 69,649,000 34,622,000 28,530,000 4,589,000 —
Business to Business — — — — — — 278,859,000 211,224,000
Business to Consumer — — — — — — 104,088,000 46,288,000
Key facts CIK 1737927 CUSIP 138035704 13F (30d) 32 filings 27 filers Visit website Investor relations